What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.
SALT LAKE CITY, Oct. 2, 2023 /PRNewswire/ — CAO Group Inc. (CAO) is stirring the pot by launching a new program to bring patients to dental practices at no cost to the practice. CAO begins a new campaign in the U.S. aimed directly at consumers involving SheerWhite!®, an innovative and…
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, fundamental research, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain, pharmaceutical regulation and preclinical.
TORONTO, Oct. 2, 2023 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Visit http://www.xtalks.com to see our upcoming webinars:
BIOMARKERS
October 3– Precision Medicine and Alzheimer’s Disease: Overcoming Biomarker Testing Barriers for Alzheimer’s Disease Patients
CELL AND GENE THERAPY
October 5– Updates in Cell and Gene Therapy: Current Trends and Operational Considerations
October 16– Cell and Gene Therapy Clinical Trials’ Regulatory Strategies and Safety Considerations
CLINICAL TRIALS
October 3– Clinical Sample Management: Expecting the Unexpected – How to Avoid Losing a Sample
October 4– Harnessing AI for Clinical Trial Workflow Management
October 6– Patient-Centric Clinical Trials: Strategies for Accelerated Enrollment, Data Insights and Trial Success
October 10– Understanding the Power of Patients: Examples of Patient Impact on Clinical Development
October 12– Advances in oncological imaging: Tumour growth rate modelling and radiomics
October 12– Keeping up with ClinOps: Why and how to expedite delivery
October 13– Incorporating the Patient’s Voice in NASH Clinical Trials
October 18– Improve Data Reliability from MADRS and HAM-D Assessments in Clinical Trials: Scientific and Operational Recommendations
October 19– How AI is changing cancer research, the site perspective
October 26– A Step-by-Step Approach to eSource in Clinical Trials
October 27– Clinical Trial Risk Identification, Management and Reporting from Clinical Development to Marketing
October 30– The Evolution of GLP-1s in Patient-Centric Clinical Development
COMMERCIALIZATION & HEOR
October 31– Fast, Faster, Fastest: Is It Time for Automated Model Building?
DRUG DISCOVERY & DEVELOPMENT
October 10– Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products
October 11– Model Informed Drug Development: Application to Project Optimus
October 16– EEG Analysis and Animal Behavior in CNS Drug Development
October 17– Covalent Drug Discovery: Basic Principles and Analysis of Current Patent Literature
October 18– Magic Rings — How to Solve Your Parenteral Formulation Challenges with Cyclodextrins
October 24– Drug Labeling Studies in Clinical Pharmacology: Recent FDA/EMA Updates
October 31– AI: Challenges, Opportunities and Impact for Drug Discovery Teams
FUNDAMENTAL RESEARCH
October 3– Optimizing Sleep During Perimenopause and Beyond
October 6– Adaptive Immune Response in Narcolepsy Type 1
October 25– Underneath the Lost Kilos: Weight Loss in Metabolic Disease
HEALTHCARE
October 20– Beyond the Token: Why Your Healthcare Data and Integration Strategy Matters
October 23– How to Co-Design Your Solution with Patients
LABORATORY TECHNOLOGY
October 2- 4th Generation Lentiviral Vectors: An Improved Gene Delivery System
October 5– An Automated Peptide Synthesis and Purification Platform to Overcome Operational Complexity
October 6– Experiences with a Rapid Multiplex NAT System for Bloodstream Infections at a Tertiary Cancer Center
October 11– Exploring the Benefits of Parallel Multiplex Immunohistochemistry
October 13– dPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development
October 16– Cell-Free Riboswitches: Engineering and Applications
October 23– Mass-directed Fraction Collection in High Performance Liquid Chromatography
October 24– Managing Critical Lab Materials through Connected Digital Solutions
October 25– DNase-I Application for dPCR Treatments in AAV Workflows
October 27– Assay Platforms for PROTAC in Drug Discovery and Beyond
October 31– Somatic Mutations in Single-Cell Sequencing: Separating Signal from Noise
MEDICAL DEVICE
October 5– Are Sensors and Wearables Really the Future of Data Capture in Clinical Trials?
PATIENT RECRUITMENT & RETENTION
October 10– Taking a proactive and holistic approach to diversity assessment and planning
October 12– AI in Clinical Research: How to Maximize Efficiency and Patient Centricity
October 18– The Power of Community Engagement in Clinical Research
PHARMA MANUFACTURING & SUPPLY CHAIN
October 11– Upstream Process Development for Better Yield and Product Quality
October 19– 2023 RAPS Article of The Year: Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals
October 30– USP 922: The Impact of Water Activity Testing on the Quality and Stability of Tablets and Capsules
PHARMACEUTICAL REGULATION
October 20– Navigating the Future: The Evolution of REMS and the Path Ahead
PRECLINICAL
October 4– AI and Machine Learning with Advanced Preclinical Cancer Models for Improved Clinical Translation
October 30– AI in Biomedical Research: Regulatory & Technology Perspectives
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://www.xtalks.com.
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected], www.xtalks.com
SOURCE Xtalks
Implementing specific concepts for shared facilities and establishing highly flexible setups become crucial factors for the fast and efficient development of drug products. These tailored approaches allow for quicker adaptation to the unique requirements of each HPAPI, ensuring safety, and maintaining high productivity levels.
Drug developers must be proactive in their approach to adapt to the current challenges in the R&D pipeline. By effectively handling HPAPIs, devising targeted therapy solutions and employing advanced formulation technologies, they can pave the way for successful drug development in the future.
Join this webinar to get insights into the challenges and strategies in drug product development and manufacturing and the safe and flexible handling of HPAPIs.
Join experts from Aenova Group, Florent Bordet, Chief Scientific Officer (CSO); Klaus Pollinger, PhD, Head of Manufacturing Science & Technology; and Martina Breuer, PhD, Head of Operations / QP, for the live webinar on Tuesday, October 10, 2023, at 11am EDT (4pm GMT/UK).
For more information, or to register for this event, visit Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products.
ABOUT AENOVA GROUP
The Aenova Group is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. As a one-stop store, Aenova develops, produces and packages all common dosage forms, product groups and active ingredient classes from pharmaceuticals to dietary supplements for human and animal health: solid, semi-solid and liquid, sterile and non-sterile, high and low dose, OEB 1 to 5 (Occupational Exposure Band). Approximately 4,000 employees at 14 sites in Europe and the U.S. contribute to the company’s success. For more information, visit http://www.aenova-group.com.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
Ambr® 250 high-throughput 24-way bioreactor system integrated with the MODDE DOE software and bioanalyzers can be used at different stages of upstream development and upstream process optimization. Upstream process development, especially testing media, screening feeding strategy and characterizing operating conditions is performed using the resource-efficient tool.
The application of bioreactor vessels with similar geometry and aspect ratio is encouraged to simplify the scaling process between bioreactors. The identification of potential critical process parameters using multi-parallel bioreactors is followed by the definition of acceptable operation ranges. The qualifying mini-scale systems are also used as the scale-down model to mimic the process at larger scales and determine the design space based on the rich statistically relevant data. The generation of reproducible and scalable data shortens the tech transfer timeline for accelerated delivery of products to patients.
Join this webinar where Dr. Ali Abghari will discuss the importance of upstream process development in elevating titer and quality, as well as achieving a robust, scalable process.
Join Ali Abghari, PhD, Senior Scientist, Aragen, for the live webinar on Wednesday, October 11, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Upstream Process Development for Better Yield and Product Quality.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Combining chromogenic or fluorescent UltraPlex in your research with image analysis software yields large amounts of data produced in less time versus other multiplex techniques.
Join this webinar to gain insights into UltraPlex multiplex immunohistochemistry and the importance of a modular approach in designing multiplex assays.
Join Matt Levin, BSc, R&D Manager, Leica Biosystems, for the live webinar on Wednesday, October 11, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Exploring the Benefits of Parallel Multiplex Immunohistochemistry.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
SHENZHEN, Chine, 2 octobre 2023 /PRNewswire/ — La 59ème réunion annuelle de l’Association européenne pour l’étude du diabète (EASD) devrait avoir lieu du 2 au 6 octobre 2023 à Hambourg, en Allemagne. Faisant ses débuts lors de cet événement prestigieux, Shenzhen Sibionics Technology Co.,…
The clinic provides in-person medication-assisted treatment for fentanyl, meth, heroin, alcohol and other substances, bringing new hope to Montgomery County residents.
ROCKVILLE, Md., Oct. 2, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Rockville. Conveniently located just a short walk from the Rockville Rail Station, the newly established low-barrier clinic at 401 E Jefferson St, Ste. 107, is dedicated to offering primarily buprenorphine-based treatment to help individuals reclaim their lives.
Dominating headlines and infiltrating the illicit drug supply, fentanyl remains the leading cause of overdose fatalities in Maryland. According to the Maryland Overdose Data Dashboard, there were 2,056 overdose deaths in the state due to fentanyl in the 12-month period ending in May 2023. In Montgomery County alone, according to the County’s Department of Police, fatal overdoses among young people increased 120% from 2021 to 2022. Police Chief Marcus Jones credits this uptick to street drugs being laced with deadly amounts of fentanyl.
“There are people looking for other drugs…like Percocet and Adderall. Young people are buying them thinking that’s what they’re purchasing, but in reality sometimes the dealers don’t know what they’re selling. That’s the danger because fentanyl can be fatal,” said Jones in a recent interview.
Data from Ideal Option’s 2022 Annual Patient Outcomes Report for patients living in Maryland corroborates these state reports, revealing that in 2022, over half of all Maryland patients tested positive for two or more substances at enrollment, and 22% tested positive for three or more substances.
The report does offer hope, however, by underscoring the effectiveness of medication-assisted treatment in combating both fentanyl and polysubstance use. For patients who remained in Ideal Option’s care throughout 2022, lab testing displayed remarkable reductions in substance use:
The new clinic in Rockville is Ideal Option’s eighth standalone location in Maryland and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine for nearly 12 years, using buprenorphine-based medications such as Suboxone®, and currently operates 93 clinics across 11 states.
“Ideal Option will be a beacon of hope for those battling addiction in the greater Silver Spring area. It’s a place where people will be treated with compassion and dignity,” said Shanade Wells, community outreach coordinator for Ideal Option. “The services we provide truly change lives by replacing despair with hope and fostering healthier communities.”
The new outpatient clinic is open Monday – Thursday,‥7:30‥a.m. –‥6‥p.m. at 401 E Jefferson St, Ste. 107, Rockville.
Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.
Patients can make an appointment by calling 1.877.522.1275 or visiting www.idealoption.com.
About Ideal Option
Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped‥more than 70,000 patients through a network of 93 office-based‥medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are‥also‥available.
Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.
In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.
Media Contact
Olivia Roe, Ideal Option, 1 9199466644, [email protected], www.idealoption.com
SOURCE Ideal Option
Attorneys at Tittle & Perlmuter secure largest verdict in Judge Roger E. Binette’s court, second largest medical malpractice verdict in Erie County, for shortcuts that caused man’s traumatic brain injury SANDUSKY, Ohio, Oct. 2, 2023 /PRNewswire/ — A jury awarded an unprecedented $6.19…
From Oct 1st – Oct 15th, dedicated donation boxes can be found at all Ink Different tattoo shops across the country to give tattoo clients and the local community the opportunity to make a meaningful difference in the lives of local heroes and contribute to this heartwarming cause.
You can participate by bringing items that are specifically needed. The American Red Cross has provided a list of essentials to guide your donations, ensuring that our heroes receive exactly what they require:
For those who prefer to make financial contributions, Ink Different is teaming up with the Red Cross for the long haul as the first nationwide tattoo company to partner with the Red Cross to support the armed forces.
“The Red Cross is near and dear to all of us for different reasons,” shares Paul-Anthony, “With a dedicated fundraising page that we can promote in our studios nationwide to every tattoo client, every day, we hope to ensure regular donations that make a difference.”
“In an ever-changing world where the resilience of our communities are constantly challenged, the importance of steadfast partnerships with organizations dedicated to humanitarian relief cannot be overstated. Our partnership with the American Red Cross is not just a seasonal endeavor but a permanent commitment,” shares Gabe Jaksich, Ink Different’s National Program Director for Ink Different’s nationwide tattoo apprenticeship program. “Together, we will be supporting the heroes, like my son, who selflessly protect and serve our nation throughout the year.”
To contribute directly and support the “Holiday for Heroes” stop by any of Ink Different’s Tattoos locations nationwide.
You can visit https://www.redcross.org/donate/cm/inkdifferent-pub.html/ to make financial contributions.
Media Contact
Benny Hiraldo, Ink Different Tattoos, 1 1-917-227-2842, [email protected], https://inkdifferenttattoos.com/
SOURCE Ink Different Tattoos
Other key survey findings include:
“The 2023 symplr Compass Survey data indicates a huge opportunity to consolidate healthcare operations solutions and give clinicians time back for patient care, which could greatly reduce burnout and make technology easier to manage,” said BJ Schaknowski, Chief Executive Officer at symplr. ”To do so, health systems must align the right stakeholders and partners to remove barriers between IT and clinicians to stop attrition of healthcare talent.”
The 210 total survey respondents were comprised of members of CHIME, the professional organization dedicated to serving CIOs, CMIOs, CNIOs, chief digital officers, and other senior healthcare IT leaders.
symplr’s Compass Survey findings align with data from industry experts. McKinsey & Company identified a potential 10-20% time savings for nurses through digital automation addressing workforce gaps. The 2023 KLAS Healthcare Operations Report revealed over 90% of healthcare workers prioritize technology consolidation for operational efficiency. And Bain & Company’s 2023 Healthcare Provider IT Report highlighted sustained HIT spending and 75% respondents anticipate increased software and technology investments in the coming year.
To access the full survey findings, download the 2023 symplr Compass Report.
About symplr
symplr is a leader in enterprise healthcare operations software and services. For more than 30 years and with deployments in 9 of 10 U.S. hospitals, symplr has been committed to improving healthcare operations through its cloud-based solutions, driving better operations for better outcomes.
Our provider data management; workforce management; compliance, quality, and safety; and contract, supplier, and spend management solutions improve the efficiency and efficacy of healthcare operations, enabling caregivers to quickly handle administrative tasks so they have more time to do what they do best: provide high-quality patient care.
Learn how at symplr.
Media Contact
Madeleine Smith, symplr, 978-518-4528, symplr@matternow.com
SOURCE symplr
